SEC Form 4 · accession 0000919574-26-003845
Eloxx Pharmaceuticals, Inc. · ELOX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Domicilium Real Estate Fund III LP
10% Owner
Period of report
May 27, 2026
Accepted (ET)
Jun 5, 2026 · 10:44 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001035354
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par value per shareF2,F3 | May 27, 2026 | J | 113,636 | $0.00 | D | 0 | D | |
| Common Stock, $0.01 par value per shareF2,F4 | holding | — | — | — | 14,285 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre-funded WarrantF2,F5,F3 | — | May 27, 2026 | J | 113,636 | A | — | — | Common Stock, $0.01 par value per share | 113,636 | 238,422 | D |
| Pre-funded WarrantF2,F4,F5 | — | holding | — | — | — | — | — | Common Stock, $0.01 par value per share | 0 | 1,894,707 | I |
Explanation of responses
- F1Pursuant to the terms of the pre-funded warrants to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants"), Domicilium Real Estate Fund III LP (the "Fund"), exchanged 1,250,000 shares of common stock of the Issuer for pre-funded warrants to purchase an equivalent number of shares of common stock of the Issuer.
- F2These securities reflect a 11 for 1 reverse stock split effective May 29, 2026.
- F3The securities are owned directly by the Fund and may be deemed to be indirectly beneficially owned by (i) Domicilium Capital Partners LLC, ("Domicilium") the investment adviser to the Fund, (ii) Domicilium Real Estate Fund III GP LLC (the "General Partner"), the general partner of the Fund, and (iii) Daniel Simon, the managing member of Domicilium and the General Partner.
- F4The securities are owned by various entities and may be deemed to be indirectly beneficially owned by (i) Domicilium, the investment adviser to such entities and (ii) Daniel Simon, the managing member of Domicilium.
- F5The Pre-Funded Warrants have no expiration date and are exercisable at any time after the date of issuance. A holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of common stock outstanding immediately after giving effect to such exercise.
Remarks
Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.